Log in
NYSE:MYOV

Myovant Sciences SEC Filings & 10K Form

$15.46
+0.53 (+3.55 %)
(As of 10/22/2020 12:00 AM ET)
Add
Compare
Today's Range
$14.50
Now: $15.46
$15.54
50-Day Range
$13.98
MA: $18.27
$22.60
52-Week Range
$4.14
Now: $15.46
$23.04
Volume659,931 shs
Average Volume1.09 million shs
Market Capitalization$1.39 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.62

SEC Filings

Myovant Sciences (NYSE:MYOV) SEC Filings

DateFilerForm TypeView
09/17/2020
3:20 PM
KARBE FRANK (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2020
3:18 PM
Arjona Ferreira Juan Camilo (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2020
3:16 PM
Curran Terrie (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2020
3:15 PM
GUINAN MARK (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2020
3:14 PM
Gulfo Adele M. (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2020
3:13 PM
Myovant Sciences (Issuer)
POTTER MYRTLE S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2020
3:12 PM
Myovant Sciences (Issuer)
Sebelius Kathleen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2020
3:05 PM
Myovant Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/02/2020
3:47 PM
Lang Matthew (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2020
3:42 PM
Arjona Ferreira Juan Camilo (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2020
3:37 PM
KARBE FRANK (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2020
4:41 PM
Lang Matthew (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2020
4:07 PM
KARBE FRANK (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2020
4:04 PM
Lang Matthew (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2020
4:02 PM
Arjona Ferreira Juan Camilo (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2020
7:36 AM
Myovant Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/11/2020
7:33 AM
Myovant Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2020
11:15 PM
Myovant Sciences (Filer)
Form EFFECT
07/24/2020
3:07 PM
Myovant Sciences (Filer)
Form DEFA14A
07/24/2020
3:03 PM
Myovant Sciences (Filer)
Form DEF 14A
06/26/2020
3:23 PM
Arjona Ferreira Juan Camilo (Reporting)
Myovant Sciences (Issuer)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
3:16 PM
Arjona Ferreira Juan Camilo (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2020
12:25 PM
Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
2:13 PM
Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
5:05 AM
Myovant Sciences (Filer)
Form POS AM
05/18/2020
3:20 PM
Myovant Sciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
05/18/2020
3:08 PM
Myovant Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2020
10:07 AM
Myovant Sciences (Subject)
Sumitomo Chemical Co., Ltd. (Filed by)
Form SC 13D/A
05/14/2020
8:57 PM
Myovant Sciences (Filer)
Form POSASR
05/13/2020
5:50 PM
Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
3:07 PM
Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
Form 4/A
05/11/2020
3:01 PM
Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2020
8:00 AM
Myovant Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2020
2:40 PM
Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2020
4:35 PM
Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2020
10:30 AM
Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2020
1:21 PM
Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2020
5:08 AM
Myovant Sciences (Subject)
Sumitomo Chemical Co., Ltd. (Filed by)
Form SC 13D/A
04/15/2020
6:22 PM
Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/13/2020
1:25 PM
Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2020
10:20 AM
Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2020
4:16 PM
Myovant Sciences (Issuer)
Seely Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2020
4:14 PM
Myovant Sciences (Issuer)
Sablich Kim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2020
4:12 PM
Lang Matthew (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2020
4:10 PM
KARBE FRANK (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2020
4:08 PM
Arjona Ferreira Juan Camilo (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2020
12:56 PM
Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2020
2:04 PM
Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2020
9:55 AM
Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2020
10:34 AM
Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2020
12:11 PM
Myovant Sciences (Subject)
Sumitomo Chemical Co., Ltd. (Filed by)
Form SC 13D/A
03/26/2020
10:39 AM
Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2020
2:15 PM
Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2020
1:10 PM
Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2020
3:21 PM
Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2020
3:13 PM
Myovant Sciences (Subject)
Sumitomo Chemical Co., Ltd. (Filed by)
Form SC 13D/A
02/24/2020
5:38 PM
Gulfo Adele M. (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
2:20 PM
JANUS HENDERSON GROUP PLC (Filed by)
Myovant Sciences (Subject)
Form SC 13G
02/10/2020
7:44 AM
Myovant Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/10/2020
7:40 AM
Myovant Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2020
5:16 AM
Myovant Sciences (Subject)
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
Form SC 13G/A
01/24/2020
5:14 AM
Myovant Sciences (Subject)
TAKEDA PHARMACEUTICAL CO LTD (Filed by)
Form SC 13G/A
01/16/2020
4:28 PM
Myovant Sciences (Issuer)
Sablich Kim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
7:42 AM
Myovant Sciences (Subject)
Sumitomo Chemical Co., Ltd. (Filed by)
Form SC 13D
01/03/2020
5:02 PM
Dainippon Sumitomo Pharma Co Ltd (Reporting)
Myovant Sciences (Issuer)
Sumitomo Chemical Co., Ltd. (Reporting)
Sumitovant Biopharma Ltd. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/03/2020
7:05 AM
Myovant Sciences (Filer)
Form DEF 14C
12/31/2019
3:45 PM
Myovant Sciences (Issuer)
Roivant Sciences Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2019
3:45 PM
Myovant Sciences (Subject)
Roivant Sciences Ltd. (Filed by)
Form SC 13D/A
12/30/2019
6:14 PM
Lang Matthew (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2019
6:13 PM
KARBE FRANK (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2019
4:15 PM
Myovant Sciences (Issuer)
Nomura Hiroshi (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/30/2019
4:13 PM
Gulfo Adele M. (Reporting)
Myovant Sciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/30/2019
8:16 AM
Myovant Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2019
3:06 PM
Myovant Sciences (Filer)
Form PRE 14C
12/19/2019
3:25 PM
Myovant Sciences (Issuer)
Sablich Kim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2019
3:28 PM
Myovant Sciences (Issuer)
Roivant Sciences Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
5:08 PM
Myovant Sciences (Issuer)
Roivant Sciences Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2019
3:45 PM
Myovant Sciences (Subject)
Roivant Sciences Ltd. (Filed by)
Form SC 13D/A
11/27/2019
3:45 PM
Myovant Sciences (Issuer)
Roivant Sciences Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2019
8:28 PM
Myovant Sciences (Issuer)
Roivant Sciences Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
7:56 AM
Myovant Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2019
7:40 AM
Myovant Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2019
5:05 AM
Myovant Sciences (Subject)
Roivant Sciences Ltd. (Filed by)
Form SC 13D/A
10/31/2019
8:24 AM
Myovant Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2019
4:06 PM
Myovant Sciences (Subject)
Roivant Sciences Ltd. (Filed by)
Form SC 13D/A
08/27/2019
3:59 PM
Myovant Sciences (Issuer)
Sablich Kim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2019
3:58 PM
Lang Matthew (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2019
3:55 PM
KARBE FRANK (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2019
3:53 PM
Arjona Ferreira Juan Camilo (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2019
3:50 PM
Myovant Sciences (Issuer)
Torti Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2019
3:48 PM
Myovant Sciences (Issuer)
Sebelius Kathleen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2019
3:46 PM
Myovant Sciences (Issuer)
POTTER MYRTLE S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2019
3:44 PM
GUINAN MARK (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2019
3:42 PM
Curran Terrie (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2019
3:06 PM
Myovant Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2019
4:03 PM
Myovant Sciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/06/2019
3:33 PM
Myovant Sciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/25/2019
3:05 PM
Myovant Sciences (Filer)
Form DEF 14A
07/16/2019
4:29 PM
Myovant Sciences (Subject)
Roivant Sciences Ltd. (Filed by)
Form SC 13D/A
07/15/2019
8:37 PM
Lo Andrew (Reporting)
Myovant Sciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 10/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.